Health And Plant-Based Trends Will Drive Capacity Expansion
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
28 May 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
US$9.60
34.4% undervalued intrinsic discount08 Aug
US$6.30
1Y
2.1%7D
21.4%